Sign Out
Known hypersensitivity to carbamazepine and oxcarbazepine, to structurally related drugs (e.g. tricyclic antidepressants) or to any of the other components of the formulation.
Patients with atrioventricular (AV) block, bone-marrow depression or a history of hepatic porphyria (e.g. acute intermittent porphyria, variegate porphyria, porphyria cutanea tarda).
Use of Tegretol in combination with monoamine oxidase inhibitors (MAO inhibitors) is not recommended (see Interactions). MAO inhibitors should be discontinued a minimum of two weeks before initiating use of Tegretol - and even earlier if the clinical situation permits.
Tegretol 2% oral suspension contains sorbitol and is thus unsuitable for persons with fructose intolerance (hereditary problems of fructose intolerance).
In addition, it must not be used in persons hypersensitive to parabens.
Continue with Google